Governance and organizational structure

Board of Directors

The Board of Directors is comprised of representatives of Shareholders of the Fund. The Board bears general responsibility for all aspects for the administration and management of the business of the Fund. In particular, the Board of Directors is in charge of (but not limited to) the following:

  • Determine the business policy of the Fund within the framework of, and to approve major business issues in accordance with, the mission statement as set out by the General Meeting of Shareholders, the Issue Document and the Fund’s constituent documents
  • Take or, as the case may be, supervise investment decisions
  • Ensure that funding is honored and the cash and other investments are managed wisely
  • Approve the contributions of the Fund to the TA Facility
  • Oversee the Investment Manager, approve reports on the business operations of the Fund and approve the financial statements

Directors of the Fund:

Mr. Karl-Heinz Fleischhacker (Chairman)

Ms. Laure Wessemius-Chibrac

Mr. Stefan Hirche

Dr. Giuseppe Ballocchi

Ms. Claudia Huber

Investment Committee

The Investment Committee is comprised of four voting members. The Investment Committee bears general responsibility in relation to the investment decisions of the Fund and oversees the Investment Manager in ensuring the Fund is compliant at all times with the Investment Guidelines.

Members of the Investment Committee:

Mr. Karl-Heinz Fleischhacker

Mrs. Christine Lier-Tomowski

Ms. Valérie Dujardin Denouvilliez

Mr. Enrico Pini (alternate of Mr. Yves Ferreira)

Investment Manager

Symbiotics is a regulated asset manager headquartered in Switzerland, with more than 160 employees worldwide.

Symbiotics is the leading market access platform for impact investing. Over the past decade, the company has originated and structured nearly 3,700 investment transactions, worth more than USD 4.8 billion, on behalf of 425 companies in 83 emerging and frontier markets, all serving a measurable sustainable and inclusive finance objective, purchased by 50 different investment funds and institutional investors.

Symbiotics has been active in Sub-Saharan Africa since 2009 through its South African subsidiary, partnering with 100 financial institutions in 26 countries.

The investment company values are focused on the principles of independence, integrity and innovation: independence towards clients and partners with regards to investment strategies and choices, integrity of staff and work, and innovation in products and services.

Organizational structure